HKMU breaks records and soars to new heights

    HKMU breaks records and soars to new heights

    [The content of this article has been produced by our advertising partner.] Hong Kong Metropolitan University (HKMU) recently celebrated its 37th Congregation, awarding qualifications to 4,800 graduates. Along with this momentous occasion, the University conferred honorary doctorates upon Professor Sylvia Fung Yuk-kuen, Dr Ina Ho Chan Un-chan, Mr Benedict Sin Nga-yan and Professor Xu Bing,…

    Read More

      China bans sales to Japan of goods that have military uses

      BEIJING (AP) — China on Tuesday banned exports of dual-use goods that can serve military purposes to Japan, a move that comes at time of heightened tensions between the two countries over Taiwan, a self-ruled island Beijing claims as its sovereign territory. The Chinese commerce ministry said in a statement that exports of such items,…

      Read More
      Mark Cooper, Investment Partner at the UK Office for Investment, delivering his keynote presentation.

        UK unveils decade-long growth vision to Hong Kong investors

        [The content of this article has been produced by our advertising partner.] The UK set out its growth agenda in Hong Kong at the inaugural UK Investment Conference, where the country’s industrial strategy and sector opportunities in finance, life sciences, clean energy and advanced manufacturing were presented.  Hosted by the British Consulate-General Hong Kong on…

        Read More
        The LEAD framework teaching methodology has earned Professor Wu both the Faculty Teaching Excellence Awards 2022-23 (left) and the University Education Award 2024 (right)

          Leading students through open doors

          [The content of this article has been produced by our advertising partner.] Although her academic journey began at two of the world’s most prestigious institutions – first as an undergraduate at Peking University, then as a doctoral researcher at Stanford University – Professor Willow Wu has never allowed herself to be confined by the proverbial…

          Read More
          The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

            The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

            Hong Kong’s biotech fundraising momentum is expected to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China’s drug developers are worth backing again – even before they generate revenue. “Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation…

            Read More